Trial · NCT07879833
AI-Personalized Skincare Regimen for Facial Photoaging in Women
NCT07879833, Not applicable, Completed, MDalgorithms Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. AI-Personalized Skincare Regimen for Facial Photoaging in Women. Trials, record NCT07879833. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07879833
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- AI-Personalized Skincare Regimen for Facial Photoaging in Women
- NCT number
- NCT07879833
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 43 participants, actual
- Lead sponsor
- MDalgorithms Inc.
- Conditions
- Photoaging, Skin Aging
- Interventions
- AI-personalized skin longevity regimen
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Expert-Graded Facial Photoaging Parameters (Modified Griffiths 10-Point Scale) | Baseline, Week 4 and Week 12 | A trained expert grader assessed facial photoaging parameters (fine lines at the crow's feet and global face, wrinkles, firmness, elasticity, smoothness, tone evenness, radiance, dark circles, puffiness, pore appearance and overall condition) on a modified Griffiths 10-point analog scale (0 = none to 9 = severe; lower scores indicate better skin condition). Change from baseline is reported. |
| Secondary | Change From Baseline in Skin Hydration (Corneometer) | Baseline, Week 4 and Week 12 | Stratum corneum hydration measured with the Corneometer CM 825 (arbitrary units) under controlled conditions after acclimatization; higher values indicate better hydration. |
| Secondary | Change From Baseline in Transepidermal Water Loss (Tewameter) | Baseline, Week 4 and Week 12 | Skin barrier function measured as transepidermal water loss (g/m2/h) with the Tewameter TM 300/TM 330T under controlled conditions; lower values indicate better barrier function. Exploratory comparison between night-cream subgroups. |
| Secondary | Change From Baseline in Skin Firmness (Indentometer) | Baseline, Week 4 and Week 12 | Skin firmness measured with the Indentometer IDM 800 under controlled conditions. |
| Secondary | Change From Baseline in Skin Surface Topography (PRIMOS 3D Profilometry) | Baseline, Week 4 and Week 12 | Skin surface roughness (Ra), wrinkle depth (Rz) and wrinkle volume at the crow's feet, forehead and perioral areas measured by PRIMOS 3D optical profilometry. |
| Secondary | Subject Self-Assessment of Skin Parameters | Week 4 and Week 12 | Percentage of participants reporting improvement on a 15-item self-assessment questionnaire developed for this study (five-point Likert scale), including overall satisfaction with the regimen. |
| Secondary | Number of Participants With Adverse Events | Baseline through Week 12 | Tolerability assessed by recording adverse events, including product-related skin reactions, throughout the study. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07879833
GET https://conductscience.org/api/trials/v1/NCT07879833/registered